![](/img/cover-not-exists.png)
Sequencing ALK inhibitors: alectinib in crizotinib-resistant patients, a phase 2 trial by Shaw et al.
Mezquita, Laura, Besse, BenjaminVolume:
8
Language:
english
Journal:
Journal of Thoracic Disease
DOI:
10.21037/jtd.2016.11.76
Date:
November, 2016
File:
PDF, 173 KB
english, 2016